Significant Contract Modifications ($10M+) — May 20, 2026

Northrop Grumman won a $569.5M firm-fixed-price delivery order from NASA for the JPSS-2 polar satellite, with performance through April 2028. This adds a substantial, 13-year revenue stream to its space systems segment, reinforcing its competitive position in critical NOAA/NASA weather satellite programs.

RTX Corp secured a $200M cost-plus-award-fee contract from NASA for Landis flight instruments, with potential value of $506.7M through 2037. The cost-plus structure reduces profit risk, and the full-and-open competition win signals competitive strength in Earth science instrumentation.

Venatorx received a $72.1M cost-plus-fixed-fee BARDA contract for an antimicrobial resistance (AMR) antibiotic, with options up to $318.6M through 2032. This signals sustained government investment in biodefense and AMR, a high-priority national security area.

Northrop Grumman's $569.5M JPSS-2 contract is firm-fixed-price, exposing the company to cost overruns on a complex space vehicle program. Any delivery delays or technical issues could compress margins.

73% of total obligations ($1.36B) are from NASA and HHS, both civilian agencies vulnerable to Continuing Resolution (CR) uncertainty. A prolonged CR could delay option exercises or new task orders on these contracts.

Two contracts to Caltech (total $515.4M) represent 28% of total obligations. As a nonprofit, Caltech offers no direct public equity exposure, limiting investor upside from these awards.

Leidos' $98.8M DHS/CBP inspection systems contract is firm-fixed-price with a long performance period (2021-2033). Subaward concentration (22% of total) introduces execution risk if subcontractors underperform.

Northrop Grumman's JPSS-2 win positions it for follow-on polar satellite contracts (JPSS-3, JPSS-4) as NOAA/NASA modernize their weather satellite constellation. The $37.2M in options on this contract provide near-term upside.

Venatorx Pharmaceuticals' BARDA contract for AMR antibiotics taps into growing biodefense budgets. If options are exercised, total value could reach $318.6M, providing multi-year revenue visibility.

SOFTRAMS LLC, a small HUBZone firm, won a $133.7M CMS IT contract. This signals government commitment to small business set-asides in healthcare IT, benefiting other small-cap IT services firms.

NASA awarded $1.085 billion (58% of total obligations) across three contracts: Northrop Grumman (JPSS-2 spacecraft), Caltech (JPL R&D), and RTX (Landis instruments). This underscores sustained investment in polar satellite missions and early-stage space R&D.

Four contracts totaling $388.6 million (21%) went to IT and professional services firms (Deloitte, SOFTRAMS, Magellan Federal, Leidos) for civilian agencies (HHS, DOI, DHS). These are stable, recurring revenue streams but offer limited margin expansion.

Two HHS/BARDA contracts totaling $134.8 million (Venatorx and SELUX Diagnostics) target medical countermeasures and AMR. This aligns with growing biodefense budgets post-pandemic.

{"entity"=>"Northrop Grumman (NOC)", "reason"=>"JPSS-2 contract is largest single award ($569.5M) with execution risk on fixed-price terms.", "trigger"=>"JPSS-2 delivery milestone announcements; NASA quarterly program reviews"}

{"entity"=>"Venatorx Pharmaceuticals", "reason"=>"BARDA contract has significant option upside ($318.6M potential) but small current obligation.", "trigger"=>"BARDA option exercise announcements; clinical/regulatory milestones"}

{"entity"=>"NASA/NOAA polar satellite sector", "reason"=>"JPSS-2 contract signals continued investment; follow-on JPSS-3/4 procurements could benefit NOC and RTX.", "trigger"=>"NOAA JPSS-3/4 RFP release; FY2027 budget request for polar satellites"}

{"entity"=>"Leidos (LDOS)", "reason"=>"DHS/CBP inspection contract has long performance period (to 2033) with subaward concentration risk.", "trigger"=>"DHS budget for border security technology; contract modification announcements"}